As the world faces new and often untreatable viral threats, Simon Fraser University researchers have found a way to cut years ...
As the world faces new and often untreatable viral threats, Simon Fraser University researchers have found a way to cut years off the time it takes to discover antiviral drugs. The research enables ...
An illustration shows a molecule nestled inside a large lumpy green mass. According to researchers' predictions, the antiviral candidate, venetoclax (red and purple), could limit SARS-CoV-2's ability ...
Influenza is an acute respiratory disease that causes epidemics and pandemics in the human population of temperate regions. Influenza epidemics occur every year during the winter months, affecting ...
The first clinical trial of an antiviral drug's effectiveness in people exposed to the deadly Ebola strain spreading in the ...
Forbes contributors publish independent expert analyses and insights. William A. Haseltine, Ph.D., covers genomics and regenerative medicine New antiviral drugs in development could offer the ...
Harvard Medical School researchers have uncovered crucial insights into how an emerging class of antiviral drugs works. The discovery sheds light on an important tool for fighting drug-resistant ...
A well-known antiviral drug commonly prescribed for herpes infections may be doing more harm than good in people with early Alzheimer’s disease, according to a new clinical trial. Rather than slowing ...
Despite national medical guidelines supporting the use of antiviral medications in young children diagnosed with influenza, a recent study reports an underuse of the treatment. "Antiviral Use Among ...
An existing drug for HIV could double as a preventative therapy for Alzheimer’s disease, according to researchers. NRTIs (nucleoside reverse transcriptase inhibitors) are antivirals that are approved ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results